Rapid UTI Assay for
Guided Therapy
Using Quantitative Microbiology
Our mission
Renascent Diagnostics
Speed. Accuracy. Efficiency.
Renascent Dx is bringing the first automated digital microbiology platform to market to provide test results faster for patients and ultimately address the worldwide issue of antibiotic resistance that is affecting every area of clinical medical practice. At Renascent Dx we believe accurate results delivered faster improves both patient care and our general health community.
Our Applications
empiriSTAT- UTI
Renascent’s comprehensive assay for assessing urine specimens for suspicion of urinary tract infection aims to transform UTI testing. Providing enumerative values for WBCs, viable bacteria, and standardized antibiotic profiling in under 3 hours directly out of the specimen, Renascent’s empiriSTAT-UTI test is fast enough to ensure appropriate therapy early in the disease course.
Our Science
Utilizing an ultra-sensitive, automated flow cytometric platform coupled to proprietary chemistry Renascent is able to assess a multitude of parameters at an incredibly high rate to identify not just bacteria present in a sample but viable bacteria directly out of a specimen without the need for lengthy cultures. With the addition of a short incubation Renascent’s technology is able to determine the effect of a panel of antibiotics with high accuracy compared to broth microdilution and Kirby-Bauer methodologies.
Our Science Applied
Renascent Diagnostics is utilizing what we believe is the world’s most advanced cytometer platform to execute our empiriSTAT assays. With unmatched pre-analytical processing the system allows for “load-n-go” functionality, ensuring automated, standardized, and accurate assay execution.
Renascent Diagnostics has developed proprietary chemistry for its empiriSTAT UTI assay that optimizes the identification of viable bacterial cells in urine specimens within minutes. This optimization has shown very high correlation to CFU enumeration after overnight culture. This differentiation between viable and non-viable bacterial cells is the key to accurate clinical diagnosis of UTI using empiriSTAT-UTI. Viable bacteria and WBC enumeration are only minutes away with Renascent Diagnostic’s empiriSTAT-UTI.
Renascent Diagnostics has spent over 7 years optimizing both bacterial gating strategies for direct assessment of UTI out of urine specimens as well as internal QC algorithms that ensure assay integrity for each sample. Additionally, the empiriSTAT-UTI algorithms allow for rapid profiling of antibiotic effects on the bacterial population allowing for patients to initiate appropriate therapy from the start.
Robust, validated science is at the core of Renascent Diagnostics technology. With the new demands of 21st century pathology labs in mind, the Renascent empiriSTAT- UTI assay aims to redefine UTI diagnostics.
Renascent diagnostics
Our Team
Renascent Diagnostics is building out its world-class team focused on commercializing its diagnostic platform with members embodying expertise in Quality Management, IVD Manufacturing, Clinical Development, and Regulatory submissions. Additionally, RDI is establishing a team of established experts in clinical microbiology, infectious disease, and clinical care to represent its Medical Advisory Board.
Antibiotic Resistance Resources and References
Why We Need to Act
Get in Touch
Renascent Diagnostics
If you’d like to learn more about our science, the clinical benefits of rapid detection of UTI, or our business plans please feel free to fill out the information form and we will be in touch.